Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.5647 | 0.8 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0867 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.1508 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5647 | 0.8 |
Schistosoma mansoni | DNA polymerase eta | 0.0023 | 0.0867 | 0.1229 |
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.0867 | 0.1229 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.1508 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5647 | 0.8 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0125 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Brugia malayi | RNA binding protein | 0.0076 | 0.5647 | 0.5399 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.1508 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0125 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.5647 | 0.5399 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0867 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.1508 | 0.0702 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0092 | 0.7058 | 0.6779 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0092 | 0.7058 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.5647 | 0.5233 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0867 | 0.0347 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.0867 | 0.5034 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0867 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0867 | 0.0347 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0867 | 0.5034 |
Brugia malayi | hypothetical protein | 0.003 | 0.1508 | 0.1025 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.1508 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5647 | 0.8 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0867 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.0867 | 0.1229 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0867 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0092 | 0.7058 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0092 | 0.7058 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0867 | 0.1229 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.5647 | 0.8 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.1508 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0867 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.1508 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0092 | 0.7058 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0092 | 0.7058 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.0867 | 0.1229 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0867 | 0.1229 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0092 | 0.7058 | 0.6891 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.0867 | 0.1229 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.5647 | 0.5233 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.5647 | 0.5399 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0092 | 0.7058 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.0867 | 0.1229 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.0867 | 0.1229 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.5647 | 0.5233 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.1508 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0867 | 0.5034 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0867 | 0.5034 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5647 | 0.8 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0092 | 0.7058 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.1508 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.0867 | 0.5034 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0867 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.0867 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0867 | 0.5034 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5647 | 0.8 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.